ORAL CAVITY SQUAMOUS CELL CARCINOMA
Clinical trials for ORAL CAVITY SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ORAL CAVITY SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for ORAL CAVITY SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could a Two-Drug punch before surgery beat head and neck cancer?
Disease control Recruiting nowThis study tests whether giving two immunotherapy drugs (cemiplimab and CDX-1140) before surgery works better than one drug alone for people with stage III-IV head and neck cancer. About 44 participants will receive either the combo or just cemiplimab before their tumor is remove…
Matched conditions: ORAL CAVITY SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 08:38 UTC
-
Could a smaller surgery spare oral cancer patients from shoulder problems?
Disease control Recruiting nowThis study tests if a less invasive procedure called sentinel lymph node biopsy works as well as the standard neck dissection for early-stage oral cavity cancer. The sentinel biopsy removes only a few key lymph nodes, which may reduce side effects like shoulder pain and stiffness…
Matched conditions: ORAL CAVITY SQUAMOUS CELL CARCINOMA
Phase: PHASE2, PHASE3 • Sponsor: NRG Oncology • Aim: Disease control
Last updated May 26, 2026 08:35 UTC
-
Could a common food preservative help fight oral cancer?
Disease control Recruiting nowThis study looks at whether taking nisin, a natural food preservative, is safe and can improve mouth health in people with oral cavity squamous cell carcinoma. About 40 participants will take nisin before and after their standard surgery. The goal is to find the best dose and see…
Matched conditions: ORAL CAVITY SQUAMOUS CELL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated May 20, 2026 11:56 UTC
-
New weekly drug combo offers hope for head and neck cancer patients unable to take standard chemo
Disease control Recruiting nowThis study tests a weekly combination of chemotherapy (carboplatin and paclitaxel) plus immunotherapy (pembrolizumab) in 32 people with metastatic head and neck cancer who cannot take the standard drug 5-fluorouracil. The goal is to see if this regimen shrinks tumors better than …
Matched conditions: ORAL CAVITY SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated May 19, 2026 12:00 UTC
-
Immunotherapy duo shows promise in advanced oral cancer trial
Disease control Recruiting nowThis study tests whether adding two immunotherapy drugs (tiragolumab and atezolizumab) before and after standard surgery and chemoradiation can improve outcomes for people with newly diagnosed, advanced oral cavity squamous cell carcinoma that has a specific marker (PD-L1 CPS pos…
Matched conditions: ORAL CAVITY SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
New drug aims to ease painful mouth sores for head and neck cancer patients
Symptom relief Recruiting nowThis study tests if adding BMX-001 to standard care can reduce severe mouth sores caused by chemoradiation in head and neck cancer patients. About 98 adults will receive either BMX-001 or a placebo alongside their usual treatment. The goal is to see if BMX-001 helps prevent painf…
Matched conditions: ORAL CAVITY SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: NRG Oncology • Aim: Symptom relief
Last updated May 20, 2026 11:55 UTC
-
New study aims to shrink radiation zones, spare healthy tissue in head and neck cancer
Symptom relief Recruiting nowThis study tests whether giving radiation only to high-risk areas after head and neck cancer surgery can reduce side effects without raising the chance of cancer coming back. About 50 adults with certain head and neck cancers will receive a personalized radiation plan. The goal i…
Matched conditions: ORAL CAVITY SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: Olgun Elicin • Aim: Symptom relief
Last updated May 20, 2026 11:55 UTC
-
Can immune markers predict success of alternative chemoradiotherapy in head and neck cancer?
Knowledge-focused Recruiting nowThis study looks at immune markers in tumor tissue, saliva, stool, and blood from 250 patients with head and neck cancers who cannot receive the standard chemotherapy drug cisplatin. Instead, they will receive chemoradiotherapy with docetaxel. The goal is to find out which immune…
Matched conditions: ORAL CAVITY SQUAMOUS CELL CARCINOMA
Sponsor: University of Erlangen-Nürnberg Medical School • Aim: Knowledge-focused
Last updated May 26, 2026 08:32 UTC
-
Remote hearing tests could save cancer Patients' ears
Knowledge-focused Recruiting nowThis study looks at whether offering hearing tests close to home or online can help more head and neck cancer patients get their hearing checked during treatment. Chemotherapy and radiation can cause hearing loss, but many patients skip follow-up tests. The goal is to see if easi…
Matched conditions: ORAL CAVITY SQUAMOUS CELL CARCINOMA
Phase: NA • Sponsor: Emory University • Aim: Knowledge-focused
Last updated May 20, 2026 11:54 UTC